Work

MA 02.01 Evidence of Clinical Activity of Sitravatinib in Combination with Nivolumab in NSCLC Patients Progressing on Prior Checkpoint Inhibitors

Year: 2017

Type: article

Study design: Clinical Trial

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2017.09.451

Authors: T. Leal, T. Campbell, A. Mapes, K. Schneider, M.J. Staab, K. Velastegui, J. Christensen, I. Chen, A. Traynor

Institutions: University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center, Mirati Therapeutics (United States)

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2766759151

FWCI: 0.216

Cites:

Cited by: 5

Related to: 10